Combination of prophylactic subcutaneous mastectomy in a woman with a BRCA-1 gene mutation and subsequent pregnancy. Forensic medical aspect of the problem
DOI:
https://doi.org/10.24866/3033-5485/2025-1/38-44Keywords:
breast cancer, BRCA-1 mutation, preventive mastectomy, residual glandular tissue, pregnancy, lactation, court proceedingsAbstract
Risk-reducing mastectomy with BRCA-1, 2 gene mutation should be considered with the patient as part of a multidisciplinary team, which should include both an oncologist surgeon and a gynecologist oncologist, whose task is to explain the risks associated with ovarian preservation. With subcutaneous mastectomy with the preservation of the nipple-areolar complex, glandular tissue is preserved, which can cause lactation at the onset of pregnancy. These issues should be explained to patients, otherwise lawsuits against clinics and doctors who performed risk-reducing mastectomy are not excluded.
References
1. Состояние онкологической помощи населению России в 2023 году / под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. Москва: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2024. 262 с. = The state of oncological care for the population of Russia in 2023. Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, P.A. Herzen Moscow Oncology Research Institute – Branch of the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation, 2024, 262 p. (In Russ.).
2. Alaofi R.K., Nassif M.O., Al-Hajeili M.R. Prophylactic mastectomy for the prevention of breast cancer: review of the literature. Avicenna J Med. 2018. Jul-Sep; 8(3): 67–77. DOI: https://doi.org/10.4103/ajm.AJM_21_18
3. Domchek S.M. Risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers: A complex discussion. JAMA. 2019. Jan 1; 321(1): 27. DOI: https://doi.org/10.1001/jama.2018.18942
4. Gasparri M.L., Taghavi K., Fiacco E., Zuber V., Di Micco R., Gazzetta G., Valentini A., Mueller M.D., Papadia A., Gentilini O.D. Risk-reducing bilateral salpingo-oophorectomy for BRCA mutation carriers and hormonal replacement therapy: If it should rain, better a drizzle than a storm. Medicina (Kaunas). 2019. Jul 29; 55(8): 415. DOI: https://doi.org/10.3390/medicina55080415
5. Santosa K.B., Oliver J.D., Momoh A.O. Contralateral prophylactic mastectomy and implications for bre-ast reconstruction. Gland Surg. 2021. Jan; 10(1): 498–506. DOI: https://doi.org/10.21037/gs.2020.03.15
6. Chiesa F., Sacchini V.S. Risk-reducing mastectomy. Minerva ginecol. 2016. Oct; 68(5): 544-7. Epub 2016. Jan 19. PMID: 26785281. PMCID: PMC5333575.
7. Metcalfe K.A., Cil T.D., Semple J.L., Li L.D., Bagher S., Zhong T., Virani S., Narod S., Pal T. Long-term psychosocial functioning in women with bilateral prophylactic mastectomy: does preservation of the nipple-areolar complex make a difference? Ann surg oncol. 2015. Oct; 22(10): 3324-30. DOI: https://doi.org/10.1245/s10434-015-4761-3
8. Hartmann L.C., Sellers T.A., Schaid D.J., Frank T.S., Soderberg C.L., Sitta D.L., Frost M.H., Grant C.S., Donohue J.H., Woods J.E., McDonnell S.K., Vockley C.W., Deffenbaugh A., Couch F.J., Jenkins R.B. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001. Nov 7; 93(21): 1633-7. DOI: https://doi.org/10.1093/jnci/93.21.1633
9. Wu Z.Y., Kim H.J., Lee J.W., Chung I.Y., Kim J.S., Lee S.B., Son B.H., Eom J.S., Kim S.B., Gong G.Y., Kim H.H., Ahn S.H., Ko B. Breast cancer recurrence in the nipple-areola complex after nipple-sparing mastectomy with immediate breast reconstruction for invasive breast cancer. JAMA Surg. 2019. Nov 1; 154(11): 1030–1037. DOI: https://doi.org/10.1001/jamasurg.2019.2959
10. Wu Z.Y., Kim H.J., Lee J., Chung I.Y., Kim J.S., Lee S.B., Son B.H., Eom J.S., Kim S.B., Gong G.Y., Kim H.H., Ahn S.H., Ko B. Recurrence outcomes after nipple-sparing mastectomy and immediate breast reconstruction in patients with pure ductal carcinoma in situ. Ann surg oncol. 2020. May; 27(5): 1627–1635. DOI: https://doi.org/10.1245/s10434-019-08184-z
11. Christine D., Christian S.F., Ricarda K., Christine K., Daphne G.K., Carmen L., Alaa M., Baltzer P.A.T., Thomas H.H., Georg P., Paola C. Risk factors for residual fibroglandular breast tissue following a mastectomy – an overview and retrospective cohort study. BMC Cancer. 2024. Jul 18; 24(1): 856. DOI: https://doi.org/10.1186/s12885-024-12491-4
12. Franceschini G., Di Leone A., Terribile D., Sanchez M.A., Masetti R. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know. Ann Ital chir. 2019; 90: 1–2. PMID: 30872561.
13. Andersson M.N., Sund M., Svensson J., Björkgren A., Wiberg R. Prophylactic mastectomy - Correlation between skin flap thickness and residual glandular tissue evaluated postoperatively by imaging. J plast reconstr aesthet surg. 2022 Jun; 75(6): 1813–1819. DOI: https://doi.org/10.1016/j.bjps.2022.01.031
14. Fritsch H., Tumeltshammer R., Hachenberg J., Warm M., Krug B., Malter W., Eichler C. Comparison of the preoperative MRI evaluation of glandular tissue in subcutaneous mastectomy and its influence on the implant volume. Cancer diagn progn. 2024. Sep 1; 4(5): 599–604. DOI: https://doi.org/10.21873/cdp.10369
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ольга Анатольевна Дмитриева, Владимир Иосифович Апанасевич
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
